Imaging features from pretreatment CT scans are associated with clinical outcomes in nonsmall-cell lung cancer patients treated with stereotactic body radiotherapy

Medical Physics

Volumn 44, Issue 8, 2017, Pages 4341-4349

  Li, Qian ^a,b   Kim, Jongphil ^b   Balagurunathan, Yoganand ^b   Liu, Ying ^a   Latifi, Kujtim ^b   Stringfield, Olya ^b   Garcia, Alberto ^b   Moros, Eduardo G ^b   Dilling, Thomas J ^b   Schabath, Matthew B ^b   Ye, Zhaoxiang ^a   Gillies, Robert J ^b  

^a KEY LABORATORY OF CANCER PREVENTION AND THERAPY   (China)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

computed tomography; image features; radiomics; semantics; stereotactic body radiotherapy (SBRT); survival

Indexed keywords

BIOLOGICAL ORGANS; COMPUTERIZED TOMOGRAPHY; DISEASES; HAZARDS; IMAGE SEGMENTATION; PATIENT MONITORING; RADIOTHERAPY;

COMPUTED TOMOGRAPHY; CONFIDENCE INTERVAL; HAZARD RATIO; IMAGE FEATURES; IMAGING FEATURES; RADIOMIC; RECURRENCE-FREE SURVIVAL; STEREOTACTIC BODY RADIOTHERAPY; SURVIVAL;

SEMANTICS;

AGED; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CLINICAL FEATURE; CLINICAL OUTCOME; COMPUTED TOMOGRAPHY SCANNER; DISTANT METASTASIS; FEMALE; HUMAN; IMAGE ANALYSIS; LINEAR ACCELERATOR; LOCAL RECURRENCE FREE SURVIVAL; MAJOR CLINICAL STUDY; MALE; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; POST TREATMENT SURVIVAL; RECURRENCE FREE SURVIVAL; STEREOTACTIC BODY RADIATION THERAPY; X-RAY COMPUTED TOMOGRAPHY; LUNG TUMOR; RADIOSURGERY; TREATMENT OUTCOME; TUMOR RECURRENCE;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RADIOSURGERY; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 85021373375     PISSN: 00942405     EISSN: 24734209     Source Type: Journal    
DOI: 10.1002/mp.12309     Document Type: Article

References (39)

1. Timmerman R, Paulus R, Galvin J, et al., Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA. 2010; 303: 1070-1076.
2. Shirvani SM, Jiang J, Chang JY, et al., Comparative effectiveness of 5 treatment strategies for early-stage non-small cell lung cancer in the elderly. Int J Radiat Oncol. 2012; 84: 1060-1070.
3. Onishi H, Shirato H, Nagata Y, et al., Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: can SBRT be comparable to surgery? Int J Radiat Oncol. 2011; 81: 1352-1358.
4. Spratt DE, Wu AJ, Adeseye V, et al., Recurrence patterns and second primary lung cancers after stereotactic body radiation therapy for early-stage non-small-cell lung cancer: implications for surveillance. Clin Lung Cancer. 2016; 17: 177-183.
5. Zhang X, Liu H, Balter P, et al., Positron emission tomography for assessing local failure after stereotactic body radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol. 2012; 83: 1558-1565.
6. Mattonen SA, Palma DA, Haasbeek CJ, Senan S, Ward AD,. Early prediction of tumor recurrence based on CT texture changes after stereotactic ablative radiotherapy (SABR) for lung cancer. Med Phys. 2014; 41: 033502.
7. Huang K, Senthi S, Palma DA, et al., High-risk CT features for detection of local recurrence after stereotactic ablative radiotherapy for lung cancer. Radiother Oncol. 2013; 109: 51-57.
8. Chen F, Matsuo Y, Yoshizawa A, et al., Salvage lung resection for non-small cell lung cancer after stereotactic body radiotherapy in initially operable patients. J Thorac Oncol. 2010; 5: 1999-2002.
9. Na F, Wang J, Li C, Deng L, Xue J, Lu Y,. Primary tumor standardized uptake value measured on F18-fluorodeoxyglucose positron emission tomography is of prediction value for survival and local control in non-small-cell lung cancer receiving radiotherapy: meta-analysis. J Thorac Oncol. 2014; 9: 834-842.
10. Clarke K, Taremi M, Dahele M, et al., Stereotactic body radiotherapy (SBRT) for non-small cell lung cancer (NSCLC): is FDG-PET a predictor of outcome? Radiother Oncol. 2012; 104: 62-66.
11. Burdick MJ, Stephans KL, Reddy CA, Djemil T, Srinivas SM, Videtic GM,. Maximum standardized uptake value from staging FDG-PET/CT does not predict treatment outcome for early-stage non-small-cell lung cancer treated with stereotactic body radiotherapy. Int J Radiat Oncol. 2010; 78: 1033-1039.
12. Satoh Y, Nambu A, Onishi H, et al., Value of dual time point F-18 FDG-PET/CT imaging for the evaluation of prognosis and risk factors for recurrence in patients with stage I non-small cell lung cancer treated with stereotactic body radiation therapy. Eur J Radiol. 2012; 81: 3530-3534.
13. Atallah S, Cho BJ, Allibhai Z, et al., Impact of pretreatment tumor growth rate on outcome of early-stage lung cancer treated with stereotactic body radiation therapy. Int J Radiat Oncol. 2014; 89: 532-538.
14. Shultz DB, Trakul N, Abelson JA, et al., Imaging features associated with disease progression after stereotactic ablative radiotherapy for stage I non-small-cell lung cancer. Clin Lung Cancer. 2014; 15: 294-301. e293.
15. Yamamoto T, Kadoya N, Shirata Y, et al., Impact of tumor attachment to the pleura measured by a pretreatment CT image on outcome of stage I NSCLC treated with stereotactic body radiotherapy. Radiat Oncol. 2015; 10: 35.
16. Gillies RJ, Kinahan PE, Hricak H,. Radiomics: images are more than pictures, they are data. Radiology. 2016; 278: 563-577.
17. Giger M, Deasy J,. MO-FG-207B-00: state-of-the-art in radiomics in radiology and radiation oncology. Med Phys. 2016; 43: 3715-3715.
18. Lee G, Lee HY, Park H, et al., Radiomics and its emerging role in lung cancer research, imaging biomarkers and clinical management: state of the art. Eur J Radiol. 2017; 86: 297-307.
19. Sala E, Mema E, Himoto Y, et al., Unravelling tumour heterogeneity using next-generation imaging: radiomics, radiogenomics, and habitat imaging. Clin Radiol. 2017; 72: 3-10.
20. Balagurunathan Y, Gu Y, Wang H, et al., Reproducibility and prognosis of quantitative features extracted from CT images. Transl Oncol. 2014; 7: 72-87.
21. Aerts HJ,. The potential of radiomic-based phenotyping in precision medicine: a review. JAMA Oncol. 2016; 2: 1636-1642.
22. Fried DV, Tucker SL, Zhou S, et al., Prognostic value and reproducibility of pretreatment ct texture features in stage III non-small cell lung cancer. Int J Radiat Oncol. 2014; 90: 834-842.
23. Gu Y, Kumar V, Hall LO, et al., Automated delineation of lung tumors from CT images using a single click ensemble segmentation approach. Pattern Recognit. 2013; 46: 692-702.
24. Viera AJ, Garrett JM,. Understanding interobserver agreement: the kappa statistic. Fam Med. 2005; 37: 360-363.
25. Harrell FE,. Regression Modeling Strategies. New York: Springer-Verlag; 2001.
26. Storey JD,. The positive false discovery rate: a Bayesian interpretation and the q-value. Ann Stat. 2003; 31: 2013-2035.
27. Harrell FE, Lee KL, Mark DB,. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996; 15: 361-387.
28. Kaplan EL, Meier P,. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958; 53: 457-481.
29. Rich JT, Neely JG, Paniello RC, Voelker CC, Nussenbaum B, Wang EW,. A practical guide to understanding Kaplan-Meier curves. Otolaryngol Head Neck Surg. 2010; 143: 331-336.
30. Efron B,. Estimating the error rate of a prediction rule: improvement on cross-validation. J Am Stat Assoc. 1983; 78: 316-331.
31. Varma S, Simon R,. Bias in error estimation when using cross-validation for model selection. BMC Bioinform. 2006; 7: 1-8.
32. Bhatt AD, El-Ghamry MN, Dunlap NE, et al., Tumor volume change with stereotactic body radiotherapy (SBRT) for early-stage lung cancer: evaluating the potential for adaptive SBRT. Am J Clin Oncol. 2015; 38: 41-46.
33. Cohen JG, Reymond E, Lederlin M, et al., Differentiating pre-and minimally invasive from invasive adenocarcinoma using CT-features in persistent pulmonary part-solid nodules in Caucasian patients. Eur J Radiol. 2015; 84: 738-744.
34. Webb WR,. The pleural tail sign. Radiology. 1978; 127: 309-313.
35. Kessler R, Gasser B, Massard G, et al., Blood vessel invasion is a major prognostic factor in resected non-small cell lung cancer. Ann Thorac Surg. 1996; 62: 1489-1493.
36. Ruffini E, Asioli S, Filosso PL, et al., Significance of the presence of microscopic vascular invasion after complete resection of stage I-II pT1-T2N0 non-small cell lung cancer and its relation with T-size categories: did the 2009 7th edition of the TNM staging system miss something? J Thorac Oncol. 2011; 6: 319-326.
37. Tsuchiya T, Akamine S, Muraoka M, et al., Stage IA non-small cell lung cancer: vessel invasion is a poor prognostic factor and a new target of adjuvant chemotherapy. Lung Cancer. 2007; 56: 341-348.
38. Huynh E, Coroller TP, Narayan V, et al., CT-based radiomic analysis of stereotactic body radiation therapy patients with lung cancer. Radiother Oncol. 2016; 120: 258-266.
39. Nyflot MJ, Yang F, Byrd D, Bowen SR, Sandison GA, Kinahan PE,. Quantitative radiomics: impact of stochastic effects on textural feature analysis implies the need for standards. J Med Imaging (Bellingham). 2015; 2: 041002.